Introduction
The prevalence of chronic kidney disease (CKD) is estimated to be about 8-16% worldwide [1] .
Common complications of CKD include anaemia, mineral and bone disorders, cognitive decline, endstage renal disease, and eventually death [1] . In 2010, CKD was ranked 18th in the list of causes of the total number of global deaths, with an annual death rate of 16.3 per 100,000 [2] . Chronic kidney disease is a global public health problem and its burden is increasing worldwide. Diabetes, hypertension, and obesity are established risk factors for CKD [1] . Other known factors involved in its pathogenesis include glomerulonephritis, infectious diseases, environmental pollution, abuse of analgesics, pesticides, and herbal medications [3] . Though these leading factors explain a large proportion of the risk of CKD, its pathogenesis is still not fully established as several unknown factors appear to be involved. It is therefore of relevance to evaluate other putative risk factors that may aid our understanding of CKD development, have predictive or causal relevance, and which will guide the development of preventive strategies.
Gamma-glutamyltransferase (GGT), a known index of liver injury and commonly used as a marker for excessive alcohol consumption [4] , has been consistently shown to be positively related with the future risk of several chronic disease outcomes in large-scale observational cohorts [5] . Emerging evidence also suggests that GGT might also be related to the risk of CKD, however, the evidence is limited and uncertain. Targher and colleagues using data from the US National Health and Nutrition Examination Survey, found a strong and independent association between increased serum GGT and CKD [6] ; however, the temporal nature of this relationship could not be established because of the cross-sectional nature of their study design. Ryu and colleagues in the first prospective evaluation of GGT and CKD, employed a cohort of 10,337 Korean male workers with normal kidney function at baseline, and demonstrated increased GGT activity to be significantly associated with an increased risk of future CKD in a nonlinear fashion [7] . The most recent prospective cohort study conducted in urban Han Chinese also showed a positive relationship between GGT and CKD incidence [8] . The prospective relationship between GGT and CKD among general Caucasian populations has not been previously investigated. Furthermore, the long-term relevance of GGT to the risk of CKD is not known. Due to measurement errors in assays, lifestyle changes, ageing, and chronic disease, analysis using only baseline measurements of an exposure could underestimate the true strength of any aetiological association between the exposure and disease outcome (i.e. "regression dilution bias" [9] ). Given that recent evidence indicates that GGT exhibits high within-person variability [10] , previous studies may have under-estimated the association between GGT and CKD. In this context, we sought to evaluate in detail, the nature and magnitude of the prospective association of GGT with risk of CKD, using a population-based cohort of 2,338 Caucasian men from eastern Finland with apparently normal renal function at baseline. Serial measurements of GGT performed at 4 and 11 years after baseline in a subsample of study participants enabled quantification of within-person variability in GGT activity.
Materials and methods
This report was conducted according to STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines for reporting observational studies in epidemiology (Supplementary material 1).
Study design and participants
The present study is based on participants from the Kuopio Ischemic Heart Disease (KIHD) prospective cohort study, which was set up to investigate risk factors for cardiovascular disease (CVD) and other chronic disease outcomes. Details of study design and recruitment methods have been described in previous reports [11, 12] . Participants of the KIHD study constituted a representative sample of men aged 42-61 years who were living in the city of Kuopio and its surrounding rural communities in eastern 
Assessment of risk markers
The methods for the collection of blood specimens and measurements of lipids and biochemical analytes have been described previously [13] . In brief, participants were instructed to fast overnight, abstain from alcohol consumption for at least 3 days, and to keep away from smoking for at least 12 hours prior to the assessments. The blood samples were taken from study participants in the morning and serum samples were stored frozen at -80 °C before analyses. The kinetic method (Thermo Fisher Scientific, Vantaa, Finland) was used to measure GGT activity, with repeat measurements performed in a random subset of participants at 4 years and 11 years after the baseline measurements, as described in previous reports [10, 14, 15] . Serum C-reactive protein (CRP) was assessed with an immunometric assay (Immulite High Sensitivity C-Reactive Protein Assay; DPC, Los Angeles, CA, USA). The glucose dehydrogenase method (Merck, Darmstadt, Germany) was used to measure fasting plasma glucose (FPG). Participants completed self-administered health and lifestyle questionnaire for the assessment of age, smoking, alcohol consumption, socio-economic status (SES), baseline diseases, and medical history [13] . Energy expenditure of physical activity was assessed using the validated KIHD 12-month leisure-time physical activity questionnaire [16, 17] . Estimated glomerular filtration rate was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [18] using the formula: eGFR = 141 x (creatinine in mg/dl / 0.9) -1.209 x 0.993 Age
Ascertainment of incident chronic kidney disease
In the KIHD study, participants are under continuous surveillance for the development of new outcomes including CKD cases. All incident CKD cases that occurred from study entry to 2014 were included and no losses to follow-up were recorded. Chronic kidney disease outcomes were collected from the National Hospital Discharge Register data by computer linkage and a comprehensive review of available hospital records, wards of health centres, health practitioner questionnaires, and medico-legal reports. Chronic kidney disease was defined as kidney damage or glomerular filtration rate lower than 60 mL/min per 1.73 m 2 for 3 months or longer.
Statistical analyses
Prospective cohort analyses All skewed variables (GGT, CRP, and triglycerides) underwent log transformation to approximate normal distributions. Baseline characteristics were presented as means (SD) for continuous variables and percentages for categorical variables. Cox proportional hazard regression models were used to conduct time-to-event analyses after confirming assumptions of proportionality of hazards using Schoenfeld residuals [19] . We quantified and corrected for withinperson variability in values of GGT using adjusted regression dilution ratios (RDRs) which were calculated by regressing available repeat GGT measurements on baseline values [20] , as described in detail previously. To assess the shape of the relationship between GGT and CKD risk, hazard ratios (HRs) and confidence intervals (CIs) were calculated within quartiles of baseline GGT values using floating absolute risks, and these were plotted against mean values within each GGT quartile. This was to allow for comparisons across the groups irrespective of the arbitrarily chosen reference category (bottom quartile). As the association showed a linear shape in age-adjusted analysis with a relatively flat risk of CKD in multivariate analysis, GGT was modelled continuously [per 1 standard deviation (SD) increase] and as categories (quartiles) defined according to its baseline distribution. The HRs were adjusted progressively for (i) age; (ii) plus body mass index (BMI), systolic blood pressure (SBP), history of hypertension, prevalent coronary heart disease (CHD), smoking status, history of diabetes, total cholesterol, high-density lipoprotein cholesterol (HDL-C), alcohol consumption, and eGFR; and (iii) plus total energy intake, SES, physical activity, and CRP. We performed subgroup analyses using interaction tests to assess statistical evidence of any differences in hazards across categories of pre-specified individual level characteristics. All statistical analyses were conducted using Stata version 14 (Stata Corp, College Station, Texas).
Results

Baseline characteristics
Baseline characteristics of the 2,338 participants included in the present analysis are summarised in Table 1 . The mean age of study participants was 53 (SD, 5) years. Median (interquartile range) GGT value was 20 (15-33) U/L and the mean (SD) of loge GGT was 3.13 (0.65) U/L. Except for alcohol consumption, BMI, blood pressure, glucose, and CRP, baseline characteristics were generally similar across quartiles of serum GGT. Levels of alcohol consumption, BMI, blood pressure, fasting glucose, and CRP were higher in participants in the top quartile of GGT values.
Correction for within-person variability in GGT
In a random sample of 711 participants, serial measurements of GGT were taken 4 and 11 years after the baseline measurements, which yielded a total of 1,422 repeat measurements of GGT. Overall, the ageadjusted RDR of loge GGT was 0.70 (95% CI: 0.64 to 0.75), which suggests that the association of GGT with CKD risk using baseline measurements of GGT could under-estimate the risk by [(1/0.70)-1]*100 = 43%. Table 2) . The corresponding adjusted HRs per 1 SD change in usual loge GGT values were 1.37 (95% CI: 1.12 to 1.66), 1.06 (95% CI: 0.84 to 1.32), and 1.02 (95% CI: 0.81 to 1.29) respectively ( Table 2 ). There was no statistical significant evidence of effect modification by levels or categories of several clinically relevant characteristics and other risk markers (P for interaction ≥ 0.10 for each; Figure 2 ).
Gamma-glutamyltransferase and risk of chronic kidney disease
Discussion
In this large-scale population-based study of middle-aged Finnish men with apparently normal kidney function at baseline, we observed a log-linear association between GGT and risk of CKD disease in ageadjusted analysis; however, the association was less robust on further adjustment for body mass index, blood pressure, lifestyle factors, history of diabetes, and serum lipids. The statistically non-significant association remained generally consistent across several clinically relevant subgroups.
There are limited published data on the association of GGT with CKD risk. Though a previous crosssectional analysis has shown GGT to be associated with albuminuria in a Chinese population; [21] to our knowledge, only two large-scale prospective studies conducted among Asian populations have reported on the associations between GGT and risk of CKD to date [7, 8] (Supplementary Material 3) . Whiles Ryu et al. in their analysis of men without a prevalent history of hypertension or diabetes, demonstrated a nonlinear relationship to the association between GGT and CKD risk [7] ; the findings by Shen et al.
suggested a linear shape to the relationship, but the association was only statistically significant for men [8] .
Limited evidence suggests an independent association between GGT and risk of CKD and a number of potential mechanisms have been hypothesized to underlie the association. Ryu and colleagues speculated that alcohol consumption, liver disease, obesity, insulin resistance, and low-grade inflammation could underlie the association [7] . However, the authors suggested that it was unlikely that these were the main mechanisms underlying the association, as those variables were carefully accounted for in their fullyadjusted multivariate analyses. Given that GGT has pro-oxidant properties [22] and is a source of reactive oxygen species (ROS), it was further suggested GGT might contribute to the pathogenesis of CKD via mechanisms related to oxidative stress [22] . Renal ROS has been reported to cause vasoconstriction of renal vasculature, which leads to sodium retention and subsequently renal damage [23, 24] . In a recent review of the link between non-alcoholic fatty liver disease (NAFLD) and CKD, the authors postulated that the origins for this relationship were via pathways such as atherogenic dyslipidemia, dysglycemia, and the release of pro-inflammatory, pro-coagulant, and pro-fibrogenic factors, which cause kidney damage [25] . Given the strong relationship between NAFLD and GGT activity, NAFLD may be the underlying pathology in the relationship between GGT and CKD. Our null findings are at odds with previous reports and several reasons could account for the conflicting results. First, the current study may not have had adequate power due to its relatively small sample size and low event rate compared with previous studies. Second, whiles the current study had a long follow-up duration of over 20 years, the follow-up period for previous studies were shorter. Given the long-term follow-up of our cohort, the phenomenon of regression dilution may have underestimated the true association between GGT and CKD risk. [26, 27] Indeed, analysis of repeat measurements of GGT in a subsample of participants suggested that using baseline measurements of GGT could under-estimate the risk by about 40%. Third, there may be true differences, due to differences in study population characteristics such as age, race or genetic background. For instance, the current study was employed in middle-aged Caucasian men who were genetically homogenous, whiles the two previous studies were based in Asian populations who were younger. [7, 8] Our study adds to the growing literature on a potential role of GGT in the development of several chronic diseases [5, 15, [28] [29] [30] . Whether GGT may be a putative risk factor for CKD risk or a marker of underlying CKD in Caucasian populations, is still uncertain. The overall evidence on the relationship between GGT and CKD is indeed limited; therefore, further large-scale studies are warranted to investigate the associations and mechanistic studies are also needed to investigate the aetiopathogenic pathways postulated to underlie the GGT-CKD association.
Our analysis used a large-scale population-based prospective cohort design with inclusion of men who were representative of the general population with apparently normal kidney function at study entry.
There was a high response rate and follow-up was complete for all participants. Other strengths of the current analysis include the long follow-up period of over 20 years; comprehensive analysis with adjustment for a broad panel of lifestyle, socioeconomic factors, and biochemical markers which allowed adequate adjustment for several risk factors; assessment of the shape of the association and stratified analyses by several clinical relevant characteristics. Repeat measurements of GGT made within a random subset of individuals over time after baseline were available, enabling correction for within-person variability in GGT activity over the long period of follow-up. However, these were made in only a small sample of participants. Studies with repeat measurements of serum GGT in larger samples are still needed to assess its variability in greater detail. Some limitations deserve mention and these include: (i) the findings cannot be generalised to women and other populations; (ii) the potential for residual confounding which is always a limitation for observational studies of this nature; and (iii) the relatively small number of CKD cases available.
Contrary to previous evidence of an independent association between elevated GGT and increased risk of CKD in Asian populations, initial evidence of an association between GGT and CKD in middle-aged Caucasian men was confounded by body mass index, blood pressure, lifestyle factors, and lipids. Further research is needed to evaluate the prospective association between GGT and CKD risk, especially in women. 
